Health status, use of healthcare, and socio-economic implications of cancer survivorship in Portugal: results from the Fourth National Health Survey
- 174 Downloads
Understanding the morbidity and socio-economic implications of cancer survivorship is essential for a comprehensive management of oncological diseases. We compared cancer survivors (CS) with the general population regarding health status, use of healthcare resources and socio-economic condition.
We analyzed data from a representative sample of the Portuguese population aged ≥15 years (n = 35,229). We defined three groups of CS, according to the time since diagnosis and the latest cancer treatment: CS 1 diagnosis within 12 months of interview; CS 2 diagnosis more than 12 months before and treatment in the previous 12 months; CS 3 diagnosis and treatment more than 12 months before. These were compared with the general population, adjusting for differences in sex, age, and place of residence.
The prevalence of CS was 2.2 % (CS 1: 0.2 %; CS 2: 0.9 %, CS 3: 1.1 %). Self-perceived health status was worse among CS and short-time incapacity more frequent among CS 1 and CS 2. Health expenses were higher in the early stages of survivorship. Lower household income and financial difficulties were more frequent in CS 1 and CS 3 men, respectively.
This study confirmed the higher consumption of healthcare resources and worse financial situation among CS.
Implications for Cancer Survivors
Our study provides valuable information for understanding the global impact of cancer survivorship.
KeywordsNeoplasms Survival Health survey Portugal
The authors thank the National Health Systems Observatory (Observatório Nacional de Saúde), National Institute of Health Dr. Ricardo Jorge (INSA), Ministry of Health and the National Institute of Statistics (INE) for providing the data (Ministério da Saúde, Instituto Nacional de Saúde Dr. Ricardo Jorge; IP, Departamento de Epidemiologia/Instituto Nacional de Estatística: Inquérito Nacional de Saúde 2005/2006). Luís Pacheco-Figueiredo received a grant from the Fundação para a Ciência e a Tecnologia (SFRH/SINTD/60124/2009).
Conflict of interest
Luís Pacheco-Figueiredo and Nuno Lunet declare that they have no conflicts of interest.
- 6.GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide [database on the Internet]. Lyon, France: International Agency for Research on Cancer. 2013. Available from: http://globocan.iarc.fr. Accessed 11 Nov 2013.
- 9.SEER Cancer Statistics Review, 1975–2010 [database on the Internet]. National Cancer Institute. 2013. Available from: http://seer.cancer.gov/csr/1975_2010/. Accessed 11 Nov 2013.
- 10.RORENO. Sobrevivência Global, Doentes diagnosticados em 2005–06—Região Norte. Registo Oncológico Regional do Norte. 2013;Instituto Português de Oncologia do Porto, ed. Porto, 2013.Google Scholar
- 11.CDC, Prevention CfDCa. Surveillance of demographic characteristics and health behaviours among adult cancer survivors—behavioral risk factor surveillance system, United States, 2009. MMWR; 2012.Google Scholar
- 12.Hewitt M, Greenfield S, Stovall E, Editors. From cancer patient to cancer survivor: lost in transition. Committee on Cancer Survivorship: Improving Care and Quality of Life, Institute of Medicine and National Research Council; 2006.Google Scholar
- 14.INE, INSA. Inquérito Nacional Saúde 2005/2006. Instituto Nacional Estatística, Instituto Nacional Ricardo Jorge; 2009. p. 1–330.Google Scholar
- 16.Cancer prevalence statistics: approaches to estimation using cancer registry data. [database on the Internet]. Bethesda, MD: National Cancer Institute (NCI). 2010. Available from: http://srab.cancer.gov/prevalence/approaches.html. Accessed: March 4, 2011.
- 18.GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide [database on the Internet]. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://globocan.iarc.fr. Accessed 9 Nov 2013.
- 23.Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(7):1054–61. doi: 10.1200/JCO.2008.18.0950.CrossRefGoogle Scholar
- 30.Yabroff KR, Short PF, Machlin S, Dowling E, Rozjabek H, Li C, et al. Access to preventive health care for cancer survivors. Am J Prev Med. 2013;45(3):304–12. doi: 10.1016/j.amepre.2013.04.021.
- 31.Vieira M, Frutuoso A, Correia AM. Vacinação contra a Gripe Sazonal—Época 2012/2013. Administração Regional de Saúde do Norte; 2013. p. 1–2.Google Scholar
- 37.de Boer AG, Taskila T, Tamminga SJ, Frings-Dresen MH, Feuerstein M, Verbeek JH. Interventions to enhance return-to-work for cancer patients. The Cochrane database of systematic reviews. 2011(2):CD007569. doi: 10.1002/14651858.CD007569.pub2.